Quest Diagnostics to Pay $740 Million to Acquire Athena Diagnostics from Thermo Fisher

It’s a strong price to pay for this specialty clinical pathology laboratory company Today, Thermo Fisher Scientific Inc. (NYSE:TMO) announced that it was selling its Athena Diagnostics clinical pathology laboratory business to Quest Diagnostics Incorporated (NYSE:DGX). The purchase price will be $740 million, making this the highest-priced medical laboratory acquisition of 2011. Based in Worcester, Massachusetts, Athena Diagnostics is known for its expertise in diagnostic tests for...
;